Cargando…
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy
Development of drug resistance represents the major cause of cancer therapy failure, determines disease progression and results in poor prognosis for cancer patients. Different mechanisms are responsible for drug resistance. Intrinsic genetic modifications of cancer cells induce the alteration of ex...
Autores principales: | Anfossi, Simone, Calin, George A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556722/ https://www.ncbi.nlm.nih.gov/pubmed/33062956 http://dx.doi.org/10.20517/cdr.2020.04 |
Ejemplares similares
-
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
por: Salaroglio, Iris C., et al.
Publicado: (2019) -
Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions
por: Coquant, Garance, et al.
Publicado: (2021) -
Gut microbiota in brain tumors: An emerging crucial player
por: Lin, Ben, et al.
Publicado: (2023) -
Gut Microbiota as a Potential Player in Mn-Induced Neurotoxicity
por: Tinkov, Alexey A., et al.
Publicado: (2021) -
When non-coding is not enough
por: Anfossi, Simone, et al.
Publicado: (2020)